The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS
NCT00413361
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
543
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
versus hydroxychloroquine
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
[object Object]